Goldman Sachs’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $2.46M | Buy |
|
|||||
|
2017
Q3 | $193K | Buy |
|
|||||
|
2017
Q2 | $75K | Sell |
|
|||||
|
2017
Q1 | $849K | Buy |
|
|||||
|
2016
Q4 | $87K | Sell |
|
|||||
|
2016
Q3 | $614K | Buy |
|
|||||
|
2016
Q2 | $287K | Buy |
|
|||||
|
2016
Q1 | $69K | Sell |
|
|||||
|
2015
Q4 | $164K | Buy |
|
|||||
|
2015
Q3 | $74K | Sell |
|
|||||
|
2015
Q2 | $286K | Buy |
|
|||||
|
2015
Q1 | $36K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $79K | Buy |
|
|||||
|
2014
Q2 | $103K | Sell |
|
|||||
|
2014
Q1 | $109K | Buy |
|
|||||
|
2013
Q4 | $37K | Sell |
|
|||||
|
2013
Q3 | $525K | Sell |
|
|||||
|
2013
Q2 | $410K | Buy |
|